NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has entered into a co-marketing agreement with MRM Proteomics that will enable the firms to offer more complete hardware, software, and proteomics kit solutions.

Vancouver-based MRM provides protein quantitation, biomarker, and proteomic services to pharmaceutical, biotech, and diagnostics customers. The company specializes in providing highly multiplexed quantitation of proteins in biosamples from blood, cerebrospinal fluid, and urine, using isotopically labeled internal standards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.